Elytra Biomaterials
Elytra Biomaterials accelerates the development of sustainable biomaterials for medical and industrial uses. Its BEAM platform uses custom machine learning models to structure data, run predictive optimization, and guide formulation decisions. The company targets biomaterial design, including biosensors, prosthetic interfaces, wound healing, and controlled release systems. Customers are primarily R&D teams in pharma, medical devices, and materials industries, typically via a SaaS subscription. This approach reduces development cycles, lowers R&D costs, and expands scalable adoption of eco-friendly materials.
Elytra Biomaterials
Elytra Biomaterials accelerates the development of sustainable biomaterials for medical and industrial uses. Its BEAM platform uses custom machine learning models to structure data, run predictive optimization, and guide formulation decisions. The company targets biomaterial design, including biosensors, prosthetic interfaces, wound healing, and controlled release systems. Customers are primarily R&D teams in pharma, medical devices, and materials industries, typically via a SaaS subscription. This approach reduces development cycles, lowers R&D costs, and expands scalable adoption of eco-friendly materials.